SOTHEMA (CAS:SOT) Issuance of Debt: MAD551 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAS:SOT SOTHEMA CAS:SOT
78 GF Score
Price MAD355.00
GF Value MAD286.97
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is SOTHEMA Issuance of Debt?

SOTHEMA CAS:SOT 78 Issuance of Debt is MAD551 Mil as of Dec. 2025. GuruFocus rates CAS:SOT with a GF Score™ of 78/100 and a GF Value™ of MAD286.97 (Modestly Overvalued). The stock has 5 warning signs investors should review.

SOTHEMA's Issuance of Debt for the six months ended in Dec. 2025 was MAD551 Mil.

SOTHEMA's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was MAD551 Mil.

SOTHEMA Issuance of Debt Related Terms

SOTHEMA Issuance of Debt Historical Data

* Premium members only.

The historical data trend for SOTHEMA's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOTHEMA Issuance of Debt Chart

SOTHEMA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.21 80.21 154.20 200.00 550.76

SOTHEMA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 154.20 0.00 200.00 0.00 550.76
CAS:SOT
78GF Score
SOTHEMA CAS:SOT
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SOTHEMA Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was MAD551 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of MAD551 Mil mean?
SOTHEMA (CAS:SOT) has a Issuance of Debt of MAD551 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on SOTHEMA and its competitors.
Is SOTHEMA's Issuance of Debt too high?
SOTHEMA's current Issuance of Debt is MAD551 Mil. Overall, SOTHEMA has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOTHEMA's Issuance of Debt compare to LLY and JNJ?
SOTHEMA's Issuance of Debt of MAD551 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on SOTHEMA and its competitors. SOTHEMA's current Issuance of Debt is MAD551 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOTHEMA stock overvalued right now?
Based on GuruFocus' analysis, SOTHEMA (CAS:SOT) is currently considered Modestly Overvalued. The stock's GF Value™ is MAD286.97, compared to a current price of MAD355.00 — trading 23.7% above its estimated fair value. The current Issuance of Debt is MAD551 Mil. SOTHEMA's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For SOTHEMA (CAS:SOT), the current Issuance of Debt is MAD551 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SOTHEMA (CAS:SOT) Overvalued in 2026?

Based on GuruFocus' analysis, SOTHEMA stock appears to be overvalued. The current stock price of MAD355.00 is trading 23.7% above its estimated GF Value™ of MAD286.97. GuruFocus considers SOTHEMA to be Modestly Overvalued.

Key valuation signals for CAS:SOT:

  • Issuance of Debt: MAD551 Mil
  • GF Value™: MAD286.97 vs. price of MAD355.00 (23.7% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the CAS:SOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SOTHEMA Business Description

Address Centre de Bouskoura, BP no. 1, Casablanca, MAR
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
78GF Score

Get the complete analysis for CAS:SOT

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD355.00
Price
MAD286.97
GF Value